 |
|
|
This image contributed by postdoc Marie-Cecile Didiot, PhD, highlights delivery of a dose of an experimental therapeutic RNA for Huntington’s disease (shown in red) to a neuron. |
Striking microscopic imagery from the RNA Therapeutics Institute (RTI) at UMass Medical School is being featured by scientific publisher Cell Press. The images in the gallery were shared by RTI scientists from UMMS.
“This RTI/Cell Press Picture Show illustrates the breadth of research that the RTI is undertaking—from fertility complications to neurodegenerative diseases—in beautiful microscopic imagery,” said Angela Messmer-Blust, PhD, senior scientific advisor at RTI.
An image contributed by Marie-Cecile Didiot, PhD, postdoc in the lab of Anastasia Khvorova, PhD, professor of RNAi therapeutics, highlights delivery of a dose of an experimental therapeutic RNA for Huntington’s disease (shown in red) to a neuron. It is one of 18 images in the gallery.
The goal of the RTI is to create a new model for organizing molecular research that fosters rapid application of new biological discoveries to solutions for unmet needs in human health by uniting researchers studying the fundamental biology and mechanisms of cellular RNAs with those working to devise human therapies using or targeting nucleic acids. Phillip D. Zamore, PhD, Howard Hughes Medical Institute Investigator, the Gretchen Stone Cook Chair in Biomedical Sciences and professor of biochemistry & molecular pharmacology, is chair of the RTI.
Related links on UMassMedNow:
RNA Therapeutics Institute gains department status
Telegram reports on advancements in RNAi treatments
